Chronic Hypersensitivity Pneumonitis (CHP) is a chronic interstitial lung disease that occurs after longstanding or recurrent exposure to an inhaled stimulus. This disease affects many patients in our pulmonary practice. We know from prior research that living with CHP has an impact on patients’ quality of life. We have recently designed a survey that asks questions that specifically address how CHP impacts patients’ lives.

The CIBMTR does research with medical data from patients who have had a transplant or other cellular therapy and donors who donate bone marrow or peripheral blood stem cells (PBSCs). The goal of this research is to find ways to make bone marrow and PBSC transplants and other cellular therapies work better.

The purpose of storing a blood sample from donors and their recipients in the NMDP/CIBMTR Research Sample Repository is to provide cells and plasma (the liquid portion of blood) for the NMDP/CIBMTR Research Sample Repository. By studying the cells and plasma of donors and recipients, researchers may learn more about improving the tissue matching between unrelated donors and their recipients. Increasing knowledge about tissue matching could result in the improved long-term survival of bone marrow and stem cell transplant recipients.

Cord blood (CB) is blood that is taken from the umbilical cord and placenta of healthy newborn babies after childbirth. The cord blood collected from a newborn baby is called a cord blood unit. Cord blood units are stored frozen (cryopreserved) in public cord blood banks. Approximately 10,000 cord blood transplants have been performed in children and adults for blood cancers and other blood diseases in the world.

The purpose of this study is to provide cell therapy to you, which will involve the use of CliniMACS CD34 Selection Device. Your family member or an unrelated (donor) will have to undergo a stem cell collection. The donation process that your family member or the unrelated donor will undergo is standard practice. 

The primary purpose for establishing this study is to have a comprehensive source of observational data that can be used to study stem cell HSC transplantation and outcomes at Weill Cornell Medical College.

This study will collect bone marrow (BM) aspirate samples from patients with relapsed refractory multiple myeloma (RRMM) prior to the start of a new treatment regimen for the purposes of prospectively measuring single-cell mass accumulation rate (MAR) as a biomarker of patient response to that regimen.

The main purpose of the LeUprolide plus Cholinesterase Inhibition to reduce Neurological Decline in Alzheimer's (LUCINDA) study is to determine whether the medication Eligard (leuprolide acetate subcutaneous injection) may slow or prevent decline in thinking abilities and functioning in women with Alzheimer’s Disease (AD) who are also taking the medication donepezil (Aricept).

The goal of this study is to create a registry of patients with gastrointestinal malignancies. This registry will provide important information about the types of gastrointestinal cancers seen at the institution, their presentation, and course of disease. We plan to review, analyze pathological features, clinical features, and other parameters of digestive diseases as related to types of treatment, patterns of care, time to progression, and survival at NYPH-Weill Cornell Medical Center.

Why is the Sponsor conducting this study?